Product Code: ETC13310127 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market was valued at USD 2 Billion in 2024 and is expected to reach USD 4.3 Billion by 2031, growing at a compound annual growth rate of 9.00% during the forecast period (2025-2031).
The Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market is experiencing significant growth due to the rising prevalence of these conditions worldwide. Endoscopy devices play a crucial role in the diagnosis and treatment of obesity, Type II diabetes, and NASH by providing minimally invasive procedures that offer less risk and faster recovery times compared to traditional surgical methods. Technological advancements in endoscopy devices, coupled with increasing awareness among healthcare professionals and patients about the benefits of endoscopic procedures, are driving the market expansion. Additionally, the growing adoption of endoscopic bariatric therapies for weight management and metabolic disorders is further fueling market growth. Key players in the market are focusing on innovation and strategic collaborations to capitalize on the increasing demand for endoscopy devices in the management of obesity, Type II diabetes, and NASH.
The Global Endoscopy Devices market for Obesity, Type II Diabetes, and NASH is experiencing significant growth due to the rising prevalence of these conditions and the increasing adoption of minimally invasive procedures. Key trends include the development of advanced endoscopic technologies for more precise diagnosis and treatment, as well as the expansion of endoscopic procedures beyond traditional applications. Opportunities in this market lie in the untapped potential of endoscopic devices for obesity management, the growing demand for minimally invasive treatment options for Type II Diabetes and NASH, and the increasing focus on preventive healthcare measures. Companies investing in research and innovation to enhance the efficacy and safety of endoscopic devices for these conditions are poised to capitalize on the expanding market opportunities.
Some challenges faced in the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH market include limited awareness and adoption of endoscopic procedures for these conditions among healthcare providers and patients, high costs associated with endoscopic devices and procedures, regulatory hurdles in different regions, and the need for specialized training for healthcare professionals to perform these procedures effectively. Additionally, the market may face competition from alternative treatment options such as pharmaceuticals or surgical interventions, as well as the need for long-term data on the efficacy and safety of endoscopic devices for managing these conditions. Overall, overcoming these challenges will require collaboration between industry stakeholders, healthcare providers, regulatory bodies, and patient advocacy groups to promote the benefits of endoscopy in treating obesity, Type II Diabetes, and NASH.
The global endoscopy devices market for obesity, Type II diabetes, and NASH is primarily driven by the increasing prevalence of these conditions worldwide. The rising awareness about the benefits of minimally invasive procedures for the treatment of obesity, diabetes, and NASH is also fueling market growth. Additionally, technological advancements in endoscopy devices, such as improved imaging capabilities and navigation systems, are enhancing the effectiveness and safety of procedures, driving adoption rates. Moreover, the growing emphasis on early detection and treatment of these conditions to prevent complications and improve patient outcomes is further propelling the demand for endoscopy devices. The expanding healthcare infrastructure in emerging economies and supportive government initiatives to address the burden of these chronic diseases are expected to contribute significantly to the market expansion in the coming years.
Government policies related to the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market vary by region. In the United States, the FDA regulates the approval and marketing of endoscopy devices, ensuring safety and efficacy. Reimbursement policies from Medicare and private insurance companies also play a significant role in market adoption. In Europe, the CE marking process governs market entry, while health technology assessment agencies assess the cost-effectiveness of these devices. In emerging markets, government initiatives to address the growing burden of obesity, diabetes, and NASH may drive market growth through funding for healthcare infrastructure and awareness campaigns. Overall, government policies impact market access, reimbursement, and adoption of endoscopy devices for these conditions on a global scale.
The global endoscopy devices market for obesity, type II diabetes, and NASH is expected to witness significant growth in the coming years due to the rising prevalence of these conditions worldwide. Technological advancements in endoscopic procedures, coupled with increasing awareness about the benefits of minimally invasive treatments, are driving market expansion. Additionally, the growing demand for effective and less invasive treatment options for obesity, type II diabetes, and NASH is propelling the adoption of endoscopy devices in these therapeutic areas. With ongoing research and development efforts focused on enhancing the capabilities and outcomes of endoscopic procedures, the market is poised for continued growth and innovation, presenting lucrative opportunities for key market players and investors in the healthcare sector.
In the Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH market, Asia shows promising growth opportunities due to the rising prevalence of obesity and diabetes in countries like China and India. North America is a mature market with established healthcare infrastructure and high adoption rates of advanced endoscopy devices. Europe is also a key market, driven by the increasing focus on minimally invasive procedures for obesity and diabetes management. In the Middle East and Africa region, there is a growing awareness about the benefits of endoscopy devices for managing chronic conditions like NASH. Latin America is witnessing a gradual uptake of endoscopy devices for obesity and diabetes treatment, with increasing investment in healthcare infrastructure contributing to market growth in the region.
Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 & 2031F |
3.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, 2021 - 2031 |
6.1 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Endoscope, 2021 - 2031 |
6.1.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Mechanical endoscopic equipment, 2021 - 2031 |
6.1.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Visualization and documentation systems, 2021 - 2031 |
6.1.5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Accessories, 2021 - 2031 |
6.1.6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Other endoscopy equipment , 2021 - 2031 |
6.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Gastric balloon, 2021 - 2031 |
6.2.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Aspiration therapy, 2021 - 2031 |
6.2.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Endoscopic sleeve gastroplasty, 2021 - 2031 |
6.2.5 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Gastric injection, 2021 - 2031 |
6.2.6 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Lap band surgery , 2021 - 2031 |
6.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Obesity , 2021 - 2031 |
6.3.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Type II Diabetes , 2021 - 2031 |
6.3.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2021 - 2031 |
7 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
7.1 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 - 2031 |
7.2 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.5 North America Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
8.1 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
8.5 Latin America (LATAM) Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
9 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
9.1 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
9.5 Asia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
10 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
10.1 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
10.5 Africa Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
11 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
11.1 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
11.5 Europe Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
12 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Overview & Analysis |
12.1 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Procedure, 2021 - 2031 |
12.5 Middle East Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
13 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
14 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Export/Import By Countries Assessment |
15 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
15.1 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2021 & 2031F |
15.4 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
16 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
16.1 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2024 |
16.2 Global Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |